Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation
- PMID: 17261504
- DOI: 10.1532/IJH9706129
Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation
Abstract
Patients with chronic granulomatous disease (CGD) complicated by antimycotics-refractory invasive aspergillosis have an extremely poor prognosis if they cannot undergo allogeneic hematopoietic stem cell transplantation from a suitable related donor while in good clinical condition. We successfully treated a 20-year-old man with very rare McLeod phenotype CGD with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. We postulate that reduced-intensity conditioning-allogeneic hematopoietic stem cell transplantation is a promising therapeutic strategy for patients with CGD even if only unrelated-donor umbilical cord blood is available.
Similar articles
-
Successful unrelated donor cord blood transplantation for chronic granulomatous disease.Int J Hematol. 2010 May;91(4):670-2. doi: 10.1007/s12185-010-0537-5. Epub 2010 Mar 12. Int J Hematol. 2010. PMID: 20224873
-
Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.Pediatr Blood Cancer. 2006 Sep;47(3):327-9. doi: 10.1002/pbc.20865. Pediatr Blood Cancer. 2006. PMID: 16628555
-
Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation.Pediatr Blood Cancer. 2007 Dec;49(7):982-4. doi: 10.1002/pbc.21365. Pediatr Blood Cancer. 2007. PMID: 17941061
-
Successful unrelated cord blood transplantation for chronic granulomatous disease: a case report and review of the literature.Pediatr Transplant. 2009 May;13(3):384-9. doi: 10.1111/j.1399-3046.2008.00996.x. Epub 2008 Jul 9. Pediatr Transplant. 2009. PMID: 18627513 Review.
-
Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens.Biol Blood Marrow Transplant. 2004 Jan;10(1):1-22. doi: 10.1016/j.bbmt.2003.09.009. Biol Blood Marrow Transplant. 2004. PMID: 14752775 Review.
Cited by
-
Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.Bone Marrow Transplant. 2010 Jan;45(1):209-11. doi: 10.1038/bmt.2009.115. Epub 2009 Jun 8. Bone Marrow Transplant. 2010. PMID: 19503108 Free PMC article. No abstract available.
-
Chronic granulomatous disease: lessons from a rare disorder.Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S123-31. doi: 10.1016/j.bbmt.2010.09.008. Biol Blood Marrow Transplant. 2011. PMID: 21195301 Free PMC article. Review.
-
Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S31-S39. doi: 10.1093/jpids/piy015. J Pediatric Infect Dis Soc. 2018. PMID: 29746680 Free PMC article. Review.
-
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.J Allergy Clin Immunol. 2011 Jun;127(6):1319-26; quiz 1327-8. doi: 10.1016/j.jaci.2011.03.028. Epub 2011 Apr 17. J Allergy Clin Immunol. 2011. PMID: 21497887 Free PMC article. Review.
-
Successful unrelated donor cord blood transplantation for chronic granulomatous disease.Int J Hematol. 2010 May;91(4):670-2. doi: 10.1007/s12185-010-0537-5. Epub 2010 Mar 12. Int J Hematol. 2010. PMID: 20224873